Multiple sclerosis primary prevention: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 7: | Line 7: | ||
==Primary Prevention== | ==Primary Prevention== | ||
Effective measures for the primary prevention of multiple sclerosis include: | Effective measures for the [[primary prevention]] of multiple sclerosis include: | ||
==== Vitamin D supplement ==== | ==== Vitamin D supplement ==== | ||
There is some evidence demonstrating that 1000 to 4000 IU vitamin D supplement daily can reduce the incidence of multiple sclerosis.<ref name="pmid15671234">{{cite journal |vauthors=Hollis BW |title=Circulating 25-hydroxyvitamin D levels indicative of vitamin D sufficiency: implications for establishing a new effective dietary intake recommendation for vitamin D |journal=J. Nutr. |volume=135 |issue=2 |pages=317–22 |date=February 2005 |pmid=15671234 |doi= |url=}}</ref><ref name="pmid15776217">{{cite journal |vauthors=Dawson-Hughes B, Heaney RP, Holick MF, Lips P, Meunier PJ, Vieth R |title=Estimates of optimal vitamin D status |journal=Osteoporos Int |volume=16 |issue=7 |pages=713–6 |date=July 2005 |pmid=15776217 |doi=10.1007/s00198-005-1867-7 |url=}}</ref><ref name="pmid10232622">{{cite journal |vauthors=Vieth R |title=Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety |journal=Am. J. Clin. Nutr. |volume=69 |issue=5 |pages=842–56 |date=May 1999 |pmid=10232622 |doi= |url=}}</ref> | There is some evidence demonstrating that 1000 to 4000 IU [[vitamin D]] supplement daily can reduce the incidence of multiple sclerosis.<ref name="pmid15671234">{{cite journal |vauthors=Hollis BW |title=Circulating 25-hydroxyvitamin D levels indicative of vitamin D sufficiency: implications for establishing a new effective dietary intake recommendation for vitamin D |journal=J. Nutr. |volume=135 |issue=2 |pages=317–22 |date=February 2005 |pmid=15671234 |doi= |url=}}</ref><ref name="pmid15776217">{{cite journal |vauthors=Dawson-Hughes B, Heaney RP, Holick MF, Lips P, Meunier PJ, Vieth R |title=Estimates of optimal vitamin D status |journal=Osteoporos Int |volume=16 |issue=7 |pages=713–6 |date=July 2005 |pmid=15776217 |doi=10.1007/s00198-005-1867-7 |url=}}</ref><ref name="pmid10232622">{{cite journal |vauthors=Vieth R |title=Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety |journal=Am. J. Clin. Nutr. |volume=69 |issue=5 |pages=842–56 |date=May 1999 |pmid=10232622 |doi= |url=}}</ref> | ||
==== Smoking cessation ==== | ==== Smoking cessation ==== | ||
[[Smoking]] cessation proved to be beneficial in reducing the incidence of MS disease. | |||
==== Early exposure to infections ==== | ==== Early exposure to infections ==== | ||
Revision as of 21:21, 3 March 2018
|
Multiple sclerosis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Multiple sclerosis primary prevention On the Web |
|
American Roentgen Ray Society Images of Multiple sclerosis primary prevention |
|
Risk calculators and risk factors for Multiple sclerosis primary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.
Overview
Primary Prevention
Effective measures for the primary prevention of multiple sclerosis include:
Vitamin D supplement
There is some evidence demonstrating that 1000 to 4000 IU vitamin D supplement daily can reduce the incidence of multiple sclerosis.[1][2][3]
Smoking cessation
Smoking cessation proved to be beneficial in reducing the incidence of MS disease.
Early exposure to infections
References
- ↑ Hollis BW (February 2005). "Circulating 25-hydroxyvitamin D levels indicative of vitamin D sufficiency: implications for establishing a new effective dietary intake recommendation for vitamin D". J. Nutr. 135 (2): 317–22. PMID 15671234.
- ↑ Dawson-Hughes B, Heaney RP, Holick MF, Lips P, Meunier PJ, Vieth R (July 2005). "Estimates of optimal vitamin D status". Osteoporos Int. 16 (7): 713–6. doi:10.1007/s00198-005-1867-7. PMID 15776217.
- ↑ Vieth R (May 1999). "Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety". Am. J. Clin. Nutr. 69 (5): 842–56. PMID 10232622.